Ginkgo Bioworks Newsroom

All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy

Yahoo FinanceDec 18 01:00

Ginkgo Bioworks, Carnegie Mellon University Secure $9.4 Mln To Build Devices For Disease Treatment

RTTNewsDec 17 22:35

Ginkgo Bioworks Secures $9.4M Partnership With Carnegie Mellon To Develop Implantable Cell-Based Bioelectronic Devices For Treating Endocrine Disorders Under ARPA-H's REACT Program

BenzingaDec 17 21:12

Express News | Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under Arpa-H's React Program

BreakingsDec 17 21:11

Ginkgo Bioworks Awarded $9.4 Million in Partnership With Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo BioworksDec 17 13:00

Ferment Launches $20M Studio Fund to Accelerate Biotech Solutions Across Vital Industries

BusinesswireNov 22 10:55

Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Maintains Target Price $10

Futu NewsNov 19 16:36 · Ratings

BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $6

Futu NewsNov 15 21:31 · Ratings

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall StNov 15 19:58

TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 13 13:31 · Ratings

Positive Outlook for Ginkgo Bioworks: Strategic Developments and Financial Strength Bolster Buy Rating

TipRanksNov 13 12:45 · Ratings

Ginkgo Bioworks Reports Q3 Growth and Strategic Deals

TipRanksNov 13 12:36

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 13 11:48 · Conference Call

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 13 11:02

10-Q: Q3 2024 Earnings Report

SECNov 13 06:11 · Announcements

8-K: Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

SECNov 13 06:09

Ginkgo Bioworks Raises FY24 Revenue From $170M-$190M To $215M-$235M Vs $185.52M Est.

BenzingaNov 13 06:05

Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate

BenzingaNov 13 06:04

Earnings Flash (DNA) GINKGO BIOWORKS Reports Q3 Loss $-1.08

MT NewswiresNov 13 06:02

Express News | Ginkgo Bioworks Holdings Inc: Reduction in Force Is Estimated to Achieve Over $85 Mln in Annualized Savings by Mid-2025

BreakingsNov 13 06:02